Moreover, both mRNA and protein levels of IGF2BP3 were remarkably up-regulated in cutaneous squamous cell carcinoma and IGF2BP3 was also identified as a novel therapeutic target for squamous cell carcinoma (48). Here, IGF2BP3 is linked to cutaneous squamous cell carcinoma.